Treatment Guide

Botox

Also known as: OnabotulinumtoxinA, Botulinum Toxin Type A, BTX-A, Vistabel (EU)

Botox is an injectable neuromodulator made from onabotulinumtoxinA that temporarily relaxes the facial muscles responsible for dynamic wrinkles — lines formed by repetitive movement. FDA-approved for cosmetic use since 2002, it is the most performed aesthetic procedure in the world, with results lasting 3–4 months.

Vera helps you research Botox with clinical confidence — AI facial analysis, real patient results, and verified providers near you.

Download the App
Treatment type Neuromodulator
Manufacturer Allergan Aesthetics / AbbVie
Results timeline Onset in 2–5 days; full effect at 10–14 days
How long results last 3–4 months for most patients; up to 6 months with repeated treatment
Sessions typical 1 session per treatment cycle; 3–4 sessions per year for maintenance
Pain level  1 / 5 (fine needle, no numbing required)
Average cost (US) $300–$600 per area; $500–$1,500 for a full-face treatment
Downtime Minimal — redness and small bumps at injection sites resolve within 1–2 hours
US FDA classification Biologics License Application  ·  Status: Approved (NDA 103000, cosmetic 2002)

How does Botox work?

Botox works by blocking acetylcholine — the neurotransmitter that signals muscles to contract — at the neuromuscular junction[2]. When onabotulinumtoxinA is injected into a target muscle, it prevents nerve signals from reaching the muscle fibers, causing temporary paralysis. With the muscle unable to contract, the overlying skin smooths out.

The effect is reversible because nerve terminals gradually form new acetylcholine receptors and sprout new connections, restoring muscle activity over 3–4 months. Botox does not destroy muscle tissue permanently — it temporarily disrupts nerve-to-muscle signaling.

Over 9 million Botox procedures[4] are performed in the United States each year, making it the single most popular non-surgical cosmetic treatment — more than double the volume of the second most popular procedure.

The toxin itself is derived from Clostridium botulinum, but the therapeutic formulation is highly purified and administered in doses far below any systemic toxic threshold. Cosmetic Botox doses (typically 20–60 units per session) are many orders of magnitude below doses associated with systemic effects.

What can Botox treat?

Botox is FDA-approved for three cosmetic indications: glabellar lines (frown lines between the brows), lateral canthal lines (crow[3]'s feet), and forehead lines. In practice, experienced injectors treat a much broader range of concerns off-label:

  • Glabellar complex (11 lines): The primary FDA-approved cosmetic indication
  • Crow's feet: FDA-approved since 2013; typically 12 units per side
  • Forehead lines: FDA-approved since 2017; requires careful dosing to preserve natural brow position
  • Brow lift: Strategic injection around the lateral brow to create elevation
  • Masseter reduction (jaw slimming): Reduces bulk of chewing muscles for a more oval facial shape
  • Neck bands (Nefertiti lift): Relaxes platysmal bands in the neck
  • Hyperhidrosis: FDA-approved for excessive underarm sweating
  • Migraine prevention: FDA-approved (Botox, not Botox Cosmetic) for chronic migraines
  • Gummy smile correction: Limits upper lip elevation to reduce gum display on smiling

Because Botox is a muscle relaxant rather than a filler, it is most effective for dynamic wrinkles (formed by movement) rather than static wrinkles (present at rest). For deep static lines, combination with hyaluronic acid fillers often produces better results.

How is Botox different from Daxxify?

Botox and Daxxify are both neuromodulators that block acetylcholine release, but they differ in duration and formulation. Botox uses onabotulinumtoxinA stabilized with human albumin, while Daxxify (daxibotulinumtoxinA-lanm) uses a proprietary peptide excipient that allows the toxin to bind more durably to nerve terminals — extending its effect to 6 months in clinical trials versus 3–4 months for Botox.

From a practical standpoint, the key differences are:

  • Duration: Daxxify lasts ~6 months; Botox lasts 3–4 months
  • Cost: Daxxify costs $400–$800 per area vs. $300–$600 for Botox
  • Onset: Both take 2–5 days; Daxxify may have slightly faster full effect
  • Track record: Botox has 30+ years of use; Daxxify was FDA-approved in 2022
  • Indications: Botox is approved for more cosmetic areas; Daxxify is currently approved for glabellar lines only

In the SAKURA clinical trials supporting Daxxify's approval, median duration of effect was 6 months — roughly twice the typical Botox duration — with 47.7% of participants maintaining effect at 6 months.

What does the Botox treatment process look like?

A Botox treatment is one of the fastest aesthetic procedures available. Here's what to expect from consultation through results:

  1. Consultation: Your provider reviews your goals, medical history, and current medications. They assess which muscles are creating the wrinkles you want to address and determine appropriate dosing for your anatomy.
  2. Preparation: No numbing cream is typically needed. The treatment area is cleansed. You'll be asked to make specific facial expressions (frown, raise brows, squint) so the provider can map target muscles.
  3. Injection: Using a fine (30–32 gauge) needle, Botox is injected into specific muscle points. A typical glabellar treatment is 5 injection points. Total procedure time is 5–15 minutes.
  4. Immediately after: Small bumps or redness at injection sites resolve within 60 minutes. Do not massage the area or lie face-down for 4 hours to prevent migration.
  5. Days 2–5: Initial softening becomes noticeable. Forehead and glabella results tend to appear faster than crow's feet.
  6. Day 14: Full results are visible. This is when a follow-up appointment is appropriate to assess any asymmetry and add touch-up units if needed.

Who is a good candidate for Botox?

Botox is appropriate for a wide range of patients. Good candidates typically include:

  • Adults with moderate to severe dynamic wrinkles — lines that appear or deepen with facial movement
  • Patients seeking preventive treatment to slow wrinkle deepening over time
  • Those with masseter hypertrophy (enlarged jaw muscles) who want facial slimming
  • Patients with hyperhidrosis (excessive sweating) in underarms, hands, or feet
  • Chronic migraine sufferers who have not responded adequately to oral preventive medications

Botox is not appropriate for:

  • Patients with known hypersensitivity to botulinum toxin or albumin
  • Those with neuromuscular junction disorders (myasthenia gravis, Lambert-Eaton syndrome)
  • Pregnant or breastfeeding patients
  • Patients taking aminoglycosides or other medications that potentiate neuromuscular blockade
  • Static wrinkles at rest — fillers are more appropriate for these

In the pivotal FDA clinical trials for cosmetic Botox, glabellar wrinkle severity improved by at least 2 grades on a 4-point scale in 73–80% of patients at 30 days post-injection — compared to 0–7% in placebo groups.[1]

Not sure if Botox is right for you?

Vera's AI Aesthetician analyzes your facial structure and builds a personalized treatment plan for your specific concerns — not a generic quiz, an actual analysis.

Get My Facial Analysis

What are the risks and side effects of Botox?

Botox has one of the best safety records of any injectable treatment when performed by a trained provider. Common side effects are mild and transient:

  • Injection-site reactions: Redness, swelling, or bruising at the needle entry point — typically resolves within hours to days
  • Headache: Reported by a small percentage of patients, usually mild and resolving within 24–48 hours
  • Ptosis (eyelid drooping): Rare but notable — occurs in fewer than 1% of glabellar treatments; caused by toxin migration into the levator palpebrae. Usually resolves within 2–6 weeks. Eye drops (apraclonidine) can temporarily alleviate this.
  • Brow heaviness or descent: Overtreatment of the forehead can weaken muscles that hold the brows up; more common with inexperienced injectors
  • Asymmetry: Can occur with uneven dosing or facial asymmetry in the underlying anatomy; typically correctable at the 2-week follow-up
  • Paradoxical animation: Some areas may move unexpectedly if neighboring muscles compensate

Serious systemic adverse events from cosmetic doses are exceedingly rare. The FDA requires a boxed warning about theoretical distant spread of toxin, but this has not been documented with standard cosmetic doses in healthy adults.

How much does Botox cost?

Botox is priced either per unit or per area, depending on the practice. Understanding the difference is important:

  • Per unit (US): $10–$20 per unit is typical; a standard glabellar treatment uses 20–25 units ($200–$500)
  • Per area (US): $300–$600 per area (forehead, crow's feet, or glabella); bundled pricing for multiple areas can reduce per-area cost
  • Full face (US): $500–$1,500 depending on number of areas, provider experience, and market
  • Annual maintenance (US): $1,200–$4,500 for quarterly treatments across 1–3 areas

Price-per-unit is the more transparent pricing model — it lets you understand exactly what you're receiving. Beware of unusually cheap "per area" packages that may use significantly fewer units than standard dosing, leading to underwhelming results or faster wear-off.

Medical spas and dermatology offices vary significantly in pricing. Board-certified plastic surgeons and dermatologists typically charge a premium, but also have the training to manage asymmetry, ptosis, and dosing nuances more effectively.

Botox vs. Daxxify vs. Dysport

How the three most widely used neuromodulators compare across key dimensions.

Botox (OnabotulinumtoxinA) Daxxify (DaxibotulinumtoxinA) Dysport (AbobotulinumtoxinA)
Mechanism Blocks acetylcholine release; human albumin stabilizer Blocks acetylcholine release; proprietary peptide excipient Blocks acetylcholine release; smaller protein complex, wider diffusion
Results onset 2–5 days; full effect at 10–14 days 1–3 days; full effect at 7–14 days 2–5 days; full effect at 10–14 days
Longevity 3–4 months typical ~6 months in clinical trials 3–4 months (similar to Botox)
Best for All cosmetic neuromodulator indications; most versatile Patients wanting longer intervals between treatments Larger areas like forehead where diffusion is beneficial
Reversible? No (effect wears off naturally) No (effect wears off naturally) No (effect wears off naturally)
Avg cost (US) $300–$600/area; $10–$20/unit $400–$800/area $300–$500/area; $4–$8/unit (different unit scale)

See real Botox results from verified providers on Vera →

Frequently Asked Questions

Evidence-based answers to the questions patients ask most about Botox.

How long does Botox last?
Botox results typically last 3–4 months for most patients in most treatment areas. Individual variation is significant — metabolism, muscle mass in the treated area, and injection technique all affect duration. Patients who receive regular, consistent treatments often find results extend to 4–6 months over time as the muscles become conditioned to reduced activity. The masseter area (jaw slimming) tends to last longer than forehead or crow's feet treatment.
Does Botox hurt?
Most patients describe Botox injections as a brief pinch or quick sting at each injection point. The needles are very fine (30–32 gauge, similar to an insulin syringe), and the injections are fast. Most sessions involve 5–20 injection points, each taking a fraction of a second. Topical numbing cream can be requested, though most patients don't find it necessary. Discomfort is generally rated 1–2 out of 5 and resolves immediately after each injection.
What is the difference between Botox and Dysport?
Botox (onabotulinumtoxinA) and Dysport (abobotulinumtoxinA) are both botulinum toxin type A products but differ in molecular size and formulation. Dysport's smaller protein complex may allow slightly wider diffusion from the injection point, which some injectors prefer for large flat muscles like the forehead. Units are not interchangeable — approximately 2.5–3 Dysport units equal 1 Botox unit. Both produce comparable aesthetic outcomes when properly dosed, and the choice often comes down to injector familiarity and patient preference.
Can you get Botox while pregnant or breastfeeding?
No. Botox is contraindicated during pregnancy and breastfeeding. While systemic absorption from cosmetic doses is extremely minimal, no adequate human safety studies exist for pregnant or nursing patients, and all major medical organizations advise against it. Reputable providers universally decline to treat pregnant or breastfeeding patients with any neuromodulator. If you become pregnant between treatments, your results will simply wear off naturally without any known harm.
What happens when Botox wears off?
When Botox wears off, the treated muscles gradually regain their ability to contract and the dynamic wrinkles they create begin to reappear. Your face returns to its pre-treatment baseline — Botox does not accelerate aging or make wrinkles worse when discontinued. In fact, some patients who maintain consistent treatment for years find that the targeted muscles become conditioned to reduced activity, and wrinkles reappear more slowly over time. There is no "rebound effect" from stopping Botox.

Still have questions about Botox? Vera's AI Aesthetician doesn't give generic answers — it analyzes your specific skin profile, concerns, and goals to tell you what's actually relevant for you.

Get My Personalized Treatment Plan →

Your guide to science-backed beauty treatments.

Built by experts of clinical K-Beauty

4.6★  ·  25 ratings on the App Store

★★★★★

Cut through the noise

"Vera is the first app that actually helped me make sense of it all. It's like having a knowledgeable friend who's done all the homework. Game changer."

Mlymat · January 2026

Sources

  1. U.S. Food and Drug Administration. Botox Cosmetic (OnabotulinumtoxinA) — Prescribing Information. NDA 103000. FDA Drug Approvals Database. 2002.  FDA Label ↗
  2. Carruthers JDA, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992;18(1):17–21.  PubMed ↗
  3. Carruthers J, Fagien S, Matarasso SL; Botox Consensus Group. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg. 2004;114(6 Suppl):1S–22S.  PubMed ↗
  4. Hexsel D, Brum C, Porto MD, et al. Field effect of two commercial preparations of botulinum toxin type A: a prospective, double-blind, randomized clinical trial. J Am Acad Dermatol. 2012;67(2):226–232.  PubMed ↗